Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tulasne

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Molecular and Cellular Biology|November 16, 2004
Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavageDavid Tulasne, Julien Deheuninck, Filipe Calheiros Lourenco, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble formMarie-Christine Copin, Marie Lesaffre, Mélanie Berbon, et al.
Plos One|November 14, 2017
Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseasesHana Benhabiles, Sara Gonzalez-Hilarion, Séverine Amand, et al.
Molecular Oncology|October 7, 2024
Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progressionElisa Carouge, Clémence Burnichon, Martin Figeac, et al.
Oncotarget|June 23, 2018
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitorsMeriem Sarah Mekki, Alexandra Mougel, Audrey Vinchent, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 10, 2018
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC PatientsClotilde Descarpentries, Frédéric Leprêtre, Fabienne Escande, et al.
The Journal of Biological Chemistry|April 12, 2002
Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signalingKatsue Suzuki-Inoue, David Tulasne, Yang Shen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2020
Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping MutationsPhilippe Jamme, Marie Fernandes, Marie-Christine Copin, et al.
Scientific Reports|June 1, 2019
Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytesBénédicte Gnangnon, Aline Fréville, Katia Cailliau, et al.
Traffic (Copenhagen, Denmark)|June 8, 2012
Shedding-generated Met receptor fragments can be routed to either the proteasomal or the lysosomal degradation pathwayFrédéric Ancot, Catherine Leroy, Ghaffar Muharram, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Biology|November 16, 2004
Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavageDavid Tulasne, Julien Deheuninck, Filipe Calheiros Lourenco, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble formMarie-Christine Copin, Marie Lesaffre, Mélanie Berbon, et al.
Plos One|November 14, 2017
Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseasesHana Benhabiles, Sara Gonzalez-Hilarion, Séverine Amand, et al.
Molecular Oncology|October 7, 2024
Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progressionElisa Carouge, Clémence Burnichon, Martin Figeac, et al.
Oncotarget|June 23, 2018
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitorsMeriem Sarah Mekki, Alexandra Mougel, Audrey Vinchent, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 10, 2018
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC PatientsClotilde Descarpentries, Frédéric Leprêtre, Fabienne Escande, et al.
The Journal of Biological Chemistry|April 12, 2002
Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signalingKatsue Suzuki-Inoue, David Tulasne, Yang Shen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2020
Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping MutationsPhilippe Jamme, Marie Fernandes, Marie-Christine Copin, et al.
Scientific Reports|June 1, 2019
Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytesBénédicte Gnangnon, Aline Fréville, Katia Cailliau, et al.
Traffic (Copenhagen, Denmark)|June 8, 2012
Shedding-generated Met receptor fragments can be routed to either the proteasomal or the lysosomal degradation pathwayFrédéric Ancot, Catherine Leroy, Ghaffar Muharram, et al.
Pageof 7